Clinical Trial Detail


Missing content? – Request curation!

Request curation for specific Genes, variants, or PubMed publications.

Have questions, comments or suggestions? - Let us know!

Email us at :

NCT ID NCT02657928
Title Ribociclib and Letrozole in Treating Patients With Relapsed ER Positive Ovarian, Fallopian Tube, Primary Peritoneal, or Endometrial Cancer
Recruitment Completed
Gender female
Phase Phase II
Variant Requirements No
Sponsors Mayo Clinic

fallopian tube carcinoma

ovarian carcinoma

peritoneal carcinoma

endometrial cancer


Letrozole + Ribociclib

Age Groups: adult | senior
Covered Countries USA

No variant requirements are available.